Blog
50 Articles
Research Highlights from ASCO GI 2026
The latest research on drugs targeting KRAS and new immuotherapy combinations were among the highlights of ASCO GI 2026.
My Life is Good Now
When Malcolm Robertson was diagnosed with pancreatic cancer, he already knew he carried the BRCA2 mutation.
A New Triple Combination for Tumors with BRCA1/2 or PALB2 Mutations
A clinical trial is comparing a two-drug combination with a three-drug combination to see which works better for genetic mutations.
Proud to be Living with Pancreatic Cancer
Paul Suntup is a long-term survivor living with recurring pancreatic cancer. He tells other patients that they too can survive this disease.
Steely Strength to Keep Going
Long-term survivor Davi D’Agostino discovered she carries the BRCA2 mutation, which changed her treatment plan to targeted therapy.
Progress in BRCA-Related Cancers Highlighted By the Basser Center
The Basser Center for BRCA hosted a panel discussion of the latest breakthroughs and discoveries for BRCA-related cancers.
You Can Do Anything
Long-term survivor Jay Bozick carries the BRCA2 mutation, which has made newer treatments an option for his pancreatic cancer.